drugset / Trial / NCT01574898
Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the pharmacokinetic profile of nicotine following a single oral administration of three new nicotine lozenge formulations (V0474) in comparison with two reference products. The clinical and biological safety of V0474 and the lozenge acceptability will also be assessed.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Niquitin® Fresh Mint | Unknown | 4 mg | Oral |
| Subject | V0474 | Unknown | — | Oral |
| Comparator | VANILLYL ALCOHOL | Small molecule | — | Oral |
Indications
No indication recorded.